Royce & Associates LP Trinity Biotech PLC Transaction History

Royce & Associates LP

  • $10.5 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2017

Nov 13, 2017
SELL
$5.16 - $5.67 $939,852 - $1.03 Million
-182,142 Closed
0 $0
Q2 2017

Aug 07, 2017
BUY
N/A
182,142
182,142 $1.09 Million

Others Institutions Holding TRIB

# of Institutions
1
Shares Held
30.2K
Call Options Held
0
Put Options Held
0
View Full List

About TRINITY BIOTECH PLC

TRIB Quotes by TradingView
  • Ticker TRIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 38,107,600
  • Market Cap $42.7M
  • Description
  • Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious dis...
More about TRIB
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email